Sort
23,748 grants matching “melanoma”
Development of Methodologies for the In Vivo Imaging og the Effects of Novel Inhi
$223,770Neal Rosen · Sloan-Kettering Inst Can Research · P50 · FY2009 · CA
Development of Methodologies for the In Vivo Imaging og the Effects of Novel Inhi
$223,770Neal Rosen · Sloan-Kettering Inst Can Research · P50 · FY2010 · CA
LONG-CIRCULATING TUMOR-SELECTIVE DNA DELIVERY SYSTEMS
$223,725Northeastern University · R01 · FY2005 · CA
Targeting Ferroptosis in BRAF (V600E) Mutant Anaplastic Thyroid Cancer
$223,693Electron Kebebew · Stanford University · R21 · FY2023 · CA
IL-18 AND IL-IH4 GENE THERAPY TO PROMOTE INNATE AND SPECIFIC TUMOR IMMUNITY
$223,608Paul B Robbins · University Of Pittsburgh At Pittsburgh · P01 · FY2007 · CA
TUMOR ASSOCIATED DENDRITIC CELLS
$223,562University Of Pittsburgh At Pittsburgh · R01 · FY2001 · CA
Breast cancer Vaccine Strategies for HER2-Overexpressing and Lum. B Tumors
$223,540Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · P50 · FY2010 · CA
Ethanol-induced skin changes
$223,531Mayumi Fujita · University Of Colorado Denver · R21 · FY2021 · AA
DENDRITIC CELL STRATEGY TO ELICIT TUMOR REACTIVE T CELLS
$223,446University Of Pittsburgh At Pittsburgh · R01 · FY2000 · CA
Delivering miR-29a to enhance anti-viral and anti-tumor responses in vivo
$223,343Erietta Stelekati · University Of Miami School Of Medicine · R21 · FY2025 · AI
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
$223,334Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2020 · CA
Immune Responses in Cancer Therapy
$223,300University Of South Florida · R01 · FY2004 · CA
Immune Responses in Cancer Therapy
$223,300University Of South Florida · R01 · FY2001 · CA
Immune Responses in Cancer Therapy
$223,300University Of South Florida · R01 · FY2002 · CA
Immune Responses in Cancer Therapy
$223,300University Of South Florida · R01 · FY2003 · CA
WUSM CANCER AND LEUKEMIA GROUP B
$223,272Washington University · U10 · FY2000 · CA
Dissecting the Melanoma Genome
$223,208Julide T Celebi · Columbia University Health Sciences · R21 · FY2012 · CA
Core C: Biostatistics and Bioinformatics Core
$223,205Shuangge Ma · Yale University · P50 · FY2024 · CA
DNA Repair
$223,177Aziz Sancar · Univ Of North Carolina Chapel Hill · P01 · FY2007 · ES
OPTIMIZING THE PRE-CLINICAL DEVELOPMENT OF IMMUNOTHERAPEUTIC ANTIBODIES THROUGH GLYCOENGINEERING
$223,115Kevin J Yarema · Johns Hopkins University · R21 · FY2020 · CA
Novel therapeutic strategies targeting conformational plasticity of type I MAGE
$223,096Hearn Jay Cho · Icahn School Of Medicine At Mount Sinai · R21 · FY2015 · CA
TARGETED NANOCARRIER FOR SIRNA DELIVERY TO TUMOR VASCULATURE
$223,081Joseph Anthoney Vetro · University Of Nebraska Medical Center · P20 · FY2011 · RR
Radiometal Chelates for Targeted Therapy of Melanoma
$223,067Lynn Carol Francesconi · Hunter College · SC1 · FY2008 · CA
Neutralizing oxidative damage at telomeres prevents T cell dysfunction and improves adoptive cell therapies against cancer
$222,998Dayana Rivadeneira · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · CA
Novel Strategies to Treat Diffuse Midline Glioma with CAR T Cell Therapy
$222,998Richard G Vile · Mayo Clinic Rochester · R21 · FY2021 · CA